Out with old, in with new smallpox vaccine
With a new smallpox vaccine accumulating in federal stockpiles, the U.S. government is disposing of millions of doses of Dryvax, the old smallpox vaccine that relies on skin scrapings from infected
Whistleblowers allege problems with Wyeth's Prevnar
Two former Wyeth workers continue to cause controversy for Wyeth's blockbuster vaccine Prevnar. Wyeth disclosed recently that the workers'Â whistleblower suits accused the company of making false
SPOTLIGHT: Is the ricin vaccine program too expensive?
ALSO NOTED: McCain reignites autism controversy; Nanoemulsions could be key to new vaccines;
Vaccine Market North Carolina is now requiring school-age children to be vaccinated against the mumps and whooping cough. Report Shortly
Novartis opens non-profit R&D vaccine center
One of the world's biggest pharma companies is breaking its business mold for its new R&D center for vaccines. Novartis is modeling its new vaccine development center in Italy on the Novartis
Novartis to offer data on pre-pandemic jabs
Novartis hasn't given up in its pursuit of profits. The Swiss company has been making an argument for use of its experimental flu vaccine ahead of any potential outbreak. Vaccines chief Jörg
GSK's secret vaccine adjuvant draws attention
GlaxoSmithKline's success advancing two pandemic vaccines--Prepandrix and Pandemrix--relies on a secret formula that drives efficacy of a low antigen dose in these adjuvated products. According to
CDC recommends flu jab for children up to 18
The Advisory Committee on Immunization Practice has greatly expanded the population of people it's recommending for an annual flu shot. The group is urging parents to make sure everyone aged six
SPOTLIGHT: Market expands for infectious diseases
An increasing amount of global travel has caused several infectious diseases, such as Yellow Fever and West Nile Virus, to surface in developed countries after largely being restricted to
ALSO NOTED: Yellow Fever vaccine in short supply; experimental TB vaccine being tested; and much more...
Vaccine Market Argentines began lining up for vaccinations to protect them from an outbreak of yellow fever in the north of the country, Paraguay and Brazil. The World Health Organization, though, is
GSK's Rotarix wins FDA committee backing
An FDA advisory panel agreed Wednesday that GlaxoSmithKline's Rotarix vaccine was safe and effective, recommending the anti-rotavirus shot for agency approval. Rotarix is designed to help protect
Nobel winner won't give up on elusive HIV vaccine
A Nobel Prize-winning biologist says that researchers are no closer to developing a vaccine against HIV than they were 20 years ago, when the scientific quest began. The key challenge to the virus,
Can a vaccine control high blood pressure?
The Chicago Sun-Times profiles Cytos' work on a new blood pressure vaccine. Just like new development work being done on vaccines for cancer, asthma and psoriasis, the trick is to identify a protein
Flu jab missing the mark in seasonal campaign
There's growing evidence around the U.S. that the flu jab offers only marginal protection against the seasonal ailment. In Texas, doctors say this year's flu vaccine guarded against less than 30
SPOTLIGHT: Advaxis vaccine demonstrates potential
Advaxis says it is developing a vaccine that could be effective in combating cervical cancer. The company says that its vaccine has proven safe in women with advanced cervical cancer in a small
ALSO NOTED: Canada sees low takeup for free cervical cancer shots; NYU advances brain cancer vaccine; and much more...
Iomai vax patch guards against traveler's diarrhea
Iomai is touting the results of a mid-stage study of its vaccine patch for traveler's diarrhea. Iomai researchers say that the patch delivered a robust immune response among the 160 volunteers in the
Booming vaccine biz swells Sanofi's revenue
A sign of the times? When Sanofi-Aventis presented its 2007 results earlier this week, it trumpeted the 14.5 percent sales growth in its vaccines group. That's more than double its pharma growth--and
Sanofi licenses technology for new TB vaccine
Sanofi Pasteur has struck a licensing deal with the Statens Serum Institut of Denmark covering the use of its technology for a new tuberculosis vaccine. The pact includes SSI's Intercell IC31
Vaccines miss their mark in seasonal flu campaign
Each year vaccine makers create a cocktail of antigens designed to stand guard against the various versions of the flu making the rounds in winter. But this year the CDC concludes that most of the
